The global Phage Therapy market size was valued at US$ 31 million in 2023. With growing demand in downstream market, the Phage Therapy is forecast to a readjusted size of US$ 101.3 million by 2030 with a CAGR of 18.3% during review period.
The research report highlights the growth potential of the global Phage Therapy market. Phage Therapy are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Phage Therapy. 麻豆原创 players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Phage Therapy market.
Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature, and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection. phage has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture.
The major players in global Phage Therapy market include NPO Microgen, Proteon Pharmaceuticals, Phagelux, etc. The top 3 players occupy about 25% shares of the global market. North America and Europe are main markets, they occupy about 60% of the global market. DsDNA Bacteriophage is the main type, with a share over 90%. Animal Health is the main application, which holds a share about 55%.
Key Features:
The report on Phage Therapy market reflects various aspects and provide valuable insights into the industry.
麻豆原创 Size and Growth: The research report provide an overview of the current size and growth of the Phage Therapy market. It may include historical data, market segmentation by Type (e.g., DsDNA Bacteriophage, SsDNA Bacteriophage), and regional breakdowns.
麻豆原创 Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Phage Therapy market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Phage Therapy market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Phage Therapy industry. This include advancements in Phage Therapy technology, Phage Therapy new entrants, Phage Therapy new investment, and other innovations that are shaping the future of Phage Therapy.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Phage Therapy market. It includes factors influencing customer ' purchasing decisions, preferences for Phage Therapy product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Phage Therapy market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Phage Therapy market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Phage Therapy market.
麻豆原创 Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Phage Therapy industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Phage Therapy market.
麻豆原创 Segmentation:
Phage Therapy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
DsDNA Bacteriophage
SsDNA Bacteriophage
SsRNA Bacteriophage
Others
Segmentation by application
Animal Health
Aquaculture
Agriculture
Food Industry
Human Health
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
NPO Microgen
Proteon Pharmaceuticals
Phagelux
Intralytix
Micreos
Eliava BioPreparations
Locus Biosciences,Inc
Pharmex Group,LLC
Pherecydes Pharma
APS Biocontrol Ltd. (APS)
Qingdao Phagepharm Bio-tech
Fixed-Phage Limited
Zeptometrix
Phage International, Inc.
MicroMir
iNtODEWORLD, Inc.
NEXTBIOTICS
Armata Pharmaceuticals, Inc.
Innophage
Adaptive Phage Therapeutics
TechnoPhage
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Phage Therapy 麻豆原创 Size 2019-2030
2.1.2 Phage Therapy 麻豆原创 Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Phage Therapy Segment by Type
2.2.1 DsDNA Bacteriophage
2.2.2 SsDNA Bacteriophage
2.2.3 SsRNA Bacteriophage
2.2.4 Others
2.3 Phage Therapy 麻豆原创 Size by Type
2.3.1 Phage Therapy 麻豆原创 Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Phage Therapy 麻豆原创 Size 麻豆原创 Share by Type (2019-2024)
2.4 Phage Therapy Segment by Application
2.4.1 Animal Health
2.4.2 Aquaculture
2.4.3 Agriculture
2.4.4 Food Industry
2.4.5 Human Health
2.4.6 Others
2.5 Phage Therapy 麻豆原创 Size by Application
2.5.1 Phage Therapy 麻豆原创 Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Phage Therapy 麻豆原创 Size 麻豆原创 Share by Application (2019-2024)
3 Phage Therapy 麻豆原创 Size by Player
3.1 Phage Therapy 麻豆原创 Size 麻豆原创 Share by Players
3.1.1 Global Phage Therapy Revenue by Players (2019-2024)
3.1.2 Global Phage Therapy Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Phage Therapy Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Phage Therapy by Regions
4.1 Phage Therapy 麻豆原创 Size by Regions (2019-2024)
4.2 Americas Phage Therapy 麻豆原创 Size Growth (2019-2024)
4.3 APAC Phage Therapy 麻豆原创 Size Growth (2019-2024)
4.4 Europe Phage Therapy 麻豆原创 Size Growth (2019-2024)
4.5 Middle East & Africa Phage Therapy 麻豆原创 Size Growth (2019-2024)
5 Americas
5.1 Americas Phage Therapy 麻豆原创 Size by Country (2019-2024)
5.2 Americas Phage Therapy 麻豆原创 Size by Type (2019-2024)
5.3 Americas Phage Therapy 麻豆原创 Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Phage Therapy 麻豆原创 Size by Region (2019-2024)
6.2 APAC Phage Therapy 麻豆原创 Size by Type (2019-2024)
6.3 APAC Phage Therapy 麻豆原创 Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Phage Therapy by Country (2019-2024)
7.2 Europe Phage Therapy 麻豆原创 Size by Type (2019-2024)
7.3 Europe Phage Therapy 麻豆原创 Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Phage Therapy by Region (2019-2024)
8.2 Middle East & Africa Phage Therapy 麻豆原创 Size by Type (2019-2024)
8.3 Middle East & Africa Phage Therapy 麻豆原创 Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Phage Therapy 麻豆原创 Forecast
10.1 Global Phage Therapy Forecast by Regions (2025-2030)
10.1.1 Global Phage Therapy Forecast by Regions (2025-2030)
10.1.2 Americas Phage Therapy Forecast
10.1.3 APAC Phage Therapy Forecast
10.1.4 Europe Phage Therapy Forecast
10.1.5 Middle East & Africa Phage Therapy Forecast
10.2 Americas Phage Therapy Forecast by Country (2025-2030)
10.2.1 United States Phage Therapy 麻豆原创 Forecast
10.2.2 Canada Phage Therapy 麻豆原创 Forecast
10.2.3 Mexico Phage Therapy 麻豆原创 Forecast
10.2.4 Brazil Phage Therapy 麻豆原创 Forecast
10.3 APAC Phage Therapy Forecast by Region (2025-2030)
10.3.1 China Phage Therapy 麻豆原创 Forecast
10.3.2 Japan Phage Therapy 麻豆原创 Forecast
10.3.3 Korea Phage Therapy 麻豆原创 Forecast
10.3.4 Southeast Asia Phage Therapy 麻豆原创 Forecast
10.3.5 India Phage Therapy 麻豆原创 Forecast
10.3.6 Australia Phage Therapy 麻豆原创 Forecast
10.4 Europe Phage Therapy Forecast by Country (2025-2030)
10.4.1 Germany Phage Therapy 麻豆原创 Forecast
10.4.2 France Phage Therapy 麻豆原创 Forecast
10.4.3 UK Phage Therapy 麻豆原创 Forecast
10.4.4 Italy Phage Therapy 麻豆原创 Forecast
10.4.5 Russia Phage Therapy 麻豆原创 Forecast
10.5 Middle East & Africa Phage Therapy Forecast by Region (2025-2030)
10.5.1 Egypt Phage Therapy 麻豆原创 Forecast
10.5.2 South Africa Phage Therapy 麻豆原创 Forecast
10.5.3 Israel Phage Therapy 麻豆原创 Forecast
10.5.4 Turkey Phage Therapy 麻豆原创 Forecast
10.5.5 GCC Countries Phage Therapy 麻豆原创 Forecast
10.6 Global Phage Therapy Forecast by Type (2025-2030)
10.7 Global Phage Therapy Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 NPO Microgen
11.1.1 NPO Microgen Company Information
11.1.2 NPO Microgen Phage Therapy Product Offered
11.1.3 NPO Microgen Phage Therapy Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.1.4 NPO Microgen Main Business Overview
11.1.5 NPO Microgen Latest Developments
11.2 Proteon Pharmaceuticals
11.2.1 Proteon Pharmaceuticals Company Information
11.2.2 Proteon Pharmaceuticals Phage Therapy Product Offered
11.2.3 Proteon Pharmaceuticals Phage Therapy Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.2.4 Proteon Pharmaceuticals Main Business Overview
11.2.5 Proteon Pharmaceuticals Latest Developments
11.3 Phagelux
11.3.1 Phagelux Company Information
11.3.2 Phagelux Phage Therapy Product Offered
11.3.3 Phagelux Phage Therapy Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.3.4 Phagelux Main Business Overview
11.3.5 Phagelux Latest Developments
11.4 Intralytix
11.4.1 Intralytix Company Information
11.4.2 Intralytix Phage Therapy Product Offered
11.4.3 Intralytix Phage Therapy Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.4.4 Intralytix Main Business Overview
11.4.5 Intralytix Latest Developments
11.5 Micreos
11.5.1 Micreos Company Information
11.5.2 Micreos Phage Therapy Product Offered
11.5.3 Micreos Phage Therapy Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.5.4 Micreos Main Business Overview
11.5.5 Micreos Latest Developments
11.6 Eliava BioPreparations
11.6.1 Eliava BioPreparations Company Information
11.6.2 Eliava BioPreparations Phage Therapy Product Offered
11.6.3 Eliava BioPreparations Phage Therapy Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.6.4 Eliava BioPreparations Main Business Overview
11.6.5 Eliava BioPreparations Latest Developments
11.7 Locus Biosciences,Inc
11.7.1 Locus Biosciences,Inc Company Information
11.7.2 Locus Biosciences,Inc Phage Therapy Product Offered
11.7.3 Locus Biosciences,Inc Phage Therapy Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.7.4 Locus Biosciences,Inc Main Business Overview
11.7.5 Locus Biosciences,Inc Latest Developments
11.8 Pharmex Group,LLC
11.8.1 Pharmex Group,LLC Company Information
11.8.2 Pharmex Group,LLC Phage Therapy Product Offered
11.8.3 Pharmex Group,LLC Phage Therapy Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.8.4 Pharmex Group,LLC Main Business Overview
11.8.5 Pharmex Group,LLC Latest Developments
11.9 Pherecydes Pharma
11.9.1 Pherecydes Pharma Company Information
11.9.2 Pherecydes Pharma Phage Therapy Product Offered
11.9.3 Pherecydes Pharma Phage Therapy Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.9.4 Pherecydes Pharma Main Business Overview
11.9.5 Pherecydes Pharma Latest Developments
11.10 APS Biocontrol Ltd. (APS)
11.10.1 APS Biocontrol Ltd. (APS) Company Information
11.10.2 APS Biocontrol Ltd. (APS) Phage Therapy Product Offered
11.10.3 APS Biocontrol Ltd. (APS) Phage Therapy Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.10.4 APS Biocontrol Ltd. (APS) Main Business Overview
11.10.5 APS Biocontrol Ltd. (APS) Latest Developments
11.11 Qingdao Phagepharm Bio-tech
11.11.1 Qingdao Phagepharm Bio-tech Company Information
11.11.2 Qingdao Phagepharm Bio-tech Phage Therapy Product Offered
11.11.3 Qingdao Phagepharm Bio-tech Phage Therapy Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.11.4 Qingdao Phagepharm Bio-tech Main Business Overview
11.11.5 Qingdao Phagepharm Bio-tech Latest Developments
11.12 Fixed-Phage Limited
11.12.1 Fixed-Phage Limited Company Information
11.12.2 Fixed-Phage Limited Phage Therapy Product Offered
11.12.3 Fixed-Phage Limited Phage Therapy Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.12.4 Fixed-Phage Limited Main Business Overview
11.12.5 Fixed-Phage Limited Latest Developments
11.13 Zeptometrix
11.13.1 Zeptometrix Company Information
11.13.2 Zeptometrix Phage Therapy Product Offered
11.13.3 Zeptometrix Phage Therapy Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.13.4 Zeptometrix Main Business Overview
11.13.5 Zeptometrix Latest Developments
11.14 Phage International, Inc.
11.14.1 Phage International, Inc. Company Information
11.14.2 Phage International, Inc. Phage Therapy Product Offered
11.14.3 Phage International, Inc. Phage Therapy Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.14.4 Phage International, Inc. Main Business Overview
11.14.5 Phage International, Inc. Latest Developments
11.15 MicroMir
11.15.1 MicroMir Company Information
11.15.2 MicroMir Phage Therapy Product Offered
11.15.3 MicroMir Phage Therapy Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.15.4 MicroMir Main Business Overview
11.15.5 MicroMir Latest Developments
11.16 iNtODEWORLD, Inc.
11.16.1 iNtODEWORLD, Inc. Company Information
11.16.2 iNtODEWORLD, Inc. Phage Therapy Product Offered
11.16.3 iNtODEWORLD, Inc. Phage Therapy Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.16.4 iNtODEWORLD, Inc. Main Business Overview
11.16.5 iNtODEWORLD, Inc. Latest Developments
11.17 NEXTBIOTICS
11.17.1 NEXTBIOTICS Company Information
11.17.2 NEXTBIOTICS Phage Therapy Product Offered
11.17.3 NEXTBIOTICS Phage Therapy Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.17.4 NEXTBIOTICS Main Business Overview
11.17.5 NEXTBIOTICS Latest Developments
11.18 Armata Pharmaceuticals, Inc.
11.18.1 Armata Pharmaceuticals, Inc. Company Information
11.18.2 Armata Pharmaceuticals, Inc. Phage Therapy Product Offered
11.18.3 Armata Pharmaceuticals, Inc. Phage Therapy Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.18.4 Armata Pharmaceuticals, Inc. Main Business Overview
11.18.5 Armata Pharmaceuticals, Inc. Latest Developments
11.19 Innophage
11.19.1 Innophage Company Information
11.19.2 Innophage Phage Therapy Product Offered
11.19.3 Innophage Phage Therapy Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.19.4 Innophage Main Business Overview
11.19.5 Innophage Latest Developments
11.20 Adaptive Phage Therapeutics
11.20.1 Adaptive Phage Therapeutics Company Information
11.20.2 Adaptive Phage Therapeutics Phage Therapy Product Offered
11.20.3 Adaptive Phage Therapeutics Phage Therapy Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.20.4 Adaptive Phage Therapeutics Main Business Overview
11.20.5 Adaptive Phage Therapeutics Latest Developments
11.21 TechnoPhage
11.21.1 TechnoPhage Company Information
11.21.2 TechnoPhage Phage Therapy Product Offered
11.21.3 TechnoPhage Phage Therapy Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.21.4 TechnoPhage Main Business Overview
11.21.5 TechnoPhage Latest Developments
12 Research Findings and Conclusion
听
听
*If Applicable.
